NVDL (GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF) Stock Analysis - News

GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF (NVDL) is a publicly traded the market company. As of May 21, 2026, NVDL trades at $112.36 with a market cap of $0 and a P/E ratio of 0.00. NVDL moved +2.30% today. Year to date, NVDL is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces NVDL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in NVDL news today?

GraniteShares 2x Daily Nvidia ETF Gains 172%, Tops $4 Billion AUM: NVDL, GraniteShares’ 2x Daily Nvidia ETF, has grown to over $4 billion in assets and delivered a 172% return in the past 12 months, turning a $10,000 stake into more than $27,000. Total leveraged ETF assets have topped $170 billion, reflecting roughly 29% annual growth since 2022.

NVDL Key Metrics

Key financial metrics for NVDL
MetricValue
Price$112.36
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume9.11M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NVDL News

NVDL Analyst Consensus

NVDL analyst coverage data. Average price target: $0.00.

Common questions about NVDL

What changed in NVDL news today?
GraniteShares 2x Daily Nvidia ETF Gains 172%, Tops $4 Billion AUM: NVDL, GraniteShares’ 2x Daily Nvidia ETF, has grown to over $4 billion in assets and delivered a 172% return in the past 12 months, turning a $10,000 stake into more than $27,000. Total leveraged ETF assets have topped $170 billion, reflecting roughly 29% annual growth since 2022.
Does Rallies summarize NVDL news?
Yes. Rallies summarizes NVDL news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is NVDL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NVDL. It does not provide personalized investment advice.
NVDL

NVDL